| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.31B | 13.87B | 15.44B | 15.38B | 14.08B | 10.03B |
| Gross Profit | 1.83B | 2.08B | 2.65B | 3.38B | 3.87B | 2.97B |
| EBITDA | -2.86B | -2.67B | 1.46B | 2.82B | 3.38B | 2.71B |
| Net Income | -1.29B | -3.27B | 460.88M | 1.84B | 2.31B | 1.75B |
Balance Sheet | ||||||
| Total Assets | 20.35B | 20.25B | 24.05B | 22.70B | 20.18B | 13.97B |
| Cash, Cash Equivalents and Short-Term Investments | 3.60B | 5.31B | 6.07B | 4.84B | 4.92B | 5.65B |
| Total Debt | 470.82M | 506.72M | 374.54M | 157.01M | 156.29M | 270.82M |
| Total Liabilities | 8.82B | 9.10B | 9.60B | 8.58B | 7.27B | 5.32B |
| Stockholders Equity | 9.71B | 9.41B | 12.81B | 12.46B | 11.19B | 7.35B |
Cash Flow | ||||||
| Free Cash Flow | 600.50M | 320.22M | 781.90M | -1.17B | 2.56B | 2.56B |
| Operating Cash Flow | 689.57M | 428.75M | 997.64M | -933.70M | 2.64B | 2.62B |
| Investing Cash Flow | 17.69M | -571.78M | -353.42M | 1.18B | -4.41B | -894.13M |
| Financing Cash Flow | -1.17B | -614.63M | -374.00M | -837.58M | 1.10B | -876.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.53B | 4.67 | 15.52% | 4.43% | 6.54% | 3.26% | |
71 Outperform | HK$13.46B | 15.46 | 11.18% | 2.78% | -0.95% | 14.89% | |
66 Neutral | HK$19.51B | 30.82 | 1.68% | 4.94% | 7.23% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
47 Neutral | HK$2.58B | 2.65 | -12.90% | 4.41% | -10.06% | 35.81% |